1. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
   Pía Loren et al, 2022, Frontiers in Pharmacology CrossRef
2. XIST: A Meaningful Long Noncoding RNA in NSCLC Process
   Yujie Shen et al, 2021, Current Pharmaceutical Design CrossRef
3. Clinico-Pathological Importance of miR-146a in Lung Cancer
   Javaid Ahmad Wani et al, 2021, Diagnostics CrossRef
4. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
   Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
5. Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2
   Wei Li et al, 2019, BioMed Research International CrossRef
6. The miR-146a SNP Rs2910164 and miR-155 SNP rs767649 Are Risk Factors for Non-Small Cell Lung Cancer in the Iranian Population
   Neda K. Dezfuli et al, 2020, Canadian Respiratory Journal CrossRef
7. miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6
   Xiangdong Liu et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
8. MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
   Javaid Ahmad Wani et al, 2022, Diagnostics CrossRef
9. Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy
   Vladimir I. Vashchenko et al, 2021, Reviews on Clinical Pharmacology and Drug Therapy CrossRef